Abstract
Introduction and ObjectivesBenralizumab is an anti-eosinophilic monoclonal antibody that improves daily symptoms for patients with severe, uncontrolled asthma with eosinophilic inflammation. This study evaluated the association of asthma symptom improvements...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
